Revance Therapeutics Statistics
Total Valuation
Ranpak Holdings has a market cap or net worth of $292.29 million. The enterprise value is $657.59 million.
Important Dates
The next confirmed earnings date is Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ranpak Holdings has 84.23 million shares outstanding. The number of shares has increased by 0.97% in one year.
| Current Share Class | 84.23M |
| Shares Outstanding | 84.23M |
| Shares Change (YoY) | +0.97% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 8.59% |
| Owned by Institutions (%) | 49.78% |
| Float | 46.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.77 |
| Forward PS | 0.71 |
| PB Ratio | 0.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 71.29 |
| P/OCF Ratio | 8.38 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.68, with an EV/FCF ratio of 160.39.
| EV / Earnings | n/a |
| EV / Sales | 1.75 |
| EV / EBITDA | 11.68 |
| EV / EBIT | n/a |
| EV / FCF | 160.39 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.79.
| Current Ratio | 1.78 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | 6.68 |
| Debt / FCF | 105.07 |
| Interest Coverage | -0.17 |
Financial Efficiency
Return on equity (ROE) is -4.40% and return on invested capital (ROIC) is -0.34%.
| Return on Equity (ROE) | -4.40% |
| Return on Assets (ROA) | -0.30% |
| Return on Invested Capital (ROIC) | -0.34% |
| Return on Capital Employed (ROCE) | -0.51% |
| Revenue Per Employee | $468,500 |
| Profits Per Employee | -$30,375 |
| Employee Count | 800 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 8.66 |
Taxes
| Income Tax | -3.90M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.94% in the last 52 weeks. The beta is 2.71, so Ranpak Holdings's price volatility has been higher than the market average.
| Beta (5Y) | 2.71 |
| 52-Week Price Change | -51.94% |
| 50-Day Moving Average | 3.60 |
| 200-Day Moving Average | 5.47 |
| Relative Strength Index (RSI) | 41.57 |
| Average Volume (20 Days) | 342,179 |
Short Selling Information
The latest short interest is 1.98 million, so 2.35% of the outstanding shares have been sold short.
| Short Interest | 1.98M |
| Short Previous Month | 1.99M |
| Short % of Shares Out | 2.35% |
| Short % of Float | 4.25% |
| Short Ratio (days to cover) | 6.10 |
Income Statement
In the last 12 months, Ranpak Holdings had revenue of $374.80 million and -$24.30 million in losses. Loss per share was -$0.29.
| Revenue | 374.80M |
| Gross Profit | 138.40M |
| Operating Income | -5.30M |
| Pretax Income | -17.30M |
| Net Income | -24.30M |
| EBITDA | 56.30M |
| EBIT | -5.30M |
| Loss Per Share | -$0.29 |
Full Income StatementBalance Sheet
The company has $65.50 million in cash and $430.80 million in debt, giving a net cash position of -$365.30 million or -$4.34 per share.
| Cash & Cash Equivalents | 65.50M |
| Total Debt | 430.80M |
| Net Cash | -365.30M |
| Net Cash Per Share | -$4.34 |
| Equity (Book Value) | 544.10M |
| Book Value Per Share | 6.46 |
| Working Capital | 68.80M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $34.90 million and capital expenditures -$30.80 million, giving a free cash flow of $4.10 million.
| Operating Cash Flow | 34.90M |
| Capital Expenditures | -30.80M |
| Free Cash Flow | 4.10M |
| FCF Per Share | $0.05 |
Full Cash Flow StatementMargins
Gross margin is 36.93%, with operating and profit margins of -1.41% and -6.48%.
| Gross Margin | 36.93% |
| Operating Margin | -1.41% |
| Pretax Margin | -7.52% |
| Profit Margin | -6.48% |
| EBITDA Margin | 15.02% |
| EBIT Margin | -1.41% |
| FCF Margin | 1.09% |
Dividends & Yields
Ranpak Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.97% |
| Shareholder Yield | -0.97% |
| Earnings Yield | -8.31% |
| FCF Yield | 1.40% |
Analyst Forecast
The average price target for Ranpak Holdings is $5.50, which is 58.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.50 |
| Price Target Difference | 58.50% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ranpak Holdings has an Altman Z-Score of 0.78 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.78 |
| Piotroski F-Score | 3 |
